to be the least in the subglottic region (5 mm below the vocal cord) among healthy Indian adults undergoing CT, [2] with a mean coronal (95% confidence interval) diameter in the subglottic region of only 11.5 (8.7-12.8) mm in women. This makes negotiation of the subglottic region difficult. However, the tracheal dimensions have poor correlation with anthropometric indices (height, weight, or body mass index of an individual). [2] [3] [4] The only consistent observation across studies was that women have a shorter and narrower trachea. [2] [3] [4] [5] The index patient was a short-statured female and had a narrower trachea and subglottic region. The transient dilatation provided by the CRE balloon enabled the passage of a larger-sized rigid bronchoscope (external diameter of 14 mm in this case) through the anatomically normal subglottic region. Alternatively, we could have also placed the metallic Y-stent under fluoroscopy using two guidewires. However, placing Y-stent using guidewires is fraught with complications, especially when the central airway stenosis is critical. [6] In the index case, the central airway stenosis was successfully managed with a smaller-sized scope. Hence, the two-guidewire technique was possible; however, placing stent under bronchoscopic vision is preferable and hence we performed the same.
Balloon dilatation is frequently used in adults and children to dilate a stenotic segment during rigid bronchoscopy. To our knowledge, this technique of dilating a normal trachea or subglottic region to facilitate rigid bronchoscopy has not been described previously. Awareness of this technique may be useful in situations that require placement of a larger-sized rigid bronchoscope, in constitutionally smaller individuals with a normal but narrow subglottic region.
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Sir,
A 37-year-old female with squamous cell carcinoma involving the lower end of esophagus presented with worsening breathlessness and stridor. On examination, the patient was relatively short statured (150 cm tall) and appeared frail. Computed tomography (CT) of the thorax showed an esophageal mass infiltrating the mediastinal structures and lower trachea, causing luminal compromise. Flexible bronchoscopy revealed infiltration of the posterior tracheal wall beginning 5 cm below the vocal cords extending up to the carina, causing a 70% luminal occlusion of the trachea. Vocal cord, subglottic region, upper trachea, and the distal bronchial tree (beyond the carina) were normal. We planned palliation by deploying a covered metallic Y-stent using rigid bronchoscopy. Under general anesthesia (sevoflurane and propofol), intubation with a 14-mm rigid tracheobronchoscope was attempted. However, the scope could not be negotiated through the subglottic region, which was not infiltrated but anatomically small to permit the scope (outer diameter 14 mm). Hence, we intubated the trachea using an 11-mm tracheobronchoscope. The tumor was mechanically debrided, and the airway was secured. As a larger rigid bronchoscope was required for stent deployment, we reattempted intubation with a 14-mm tracheobronchoscope, but failed to negotiate the subglottic area [Supplemental Video 1] .
We now positioned the 14-mm rigid bronchoscope barrel just below the vocal cord and inflated a controlled radial expansion balloon (up to 18 mm at 4 atmospheric pressure for 10 s using CRE™ [M00558650], Boston Scientific), to dilate the anatomically normal subglottic region. The latter allowed the passage of the 14-mm tracheobronchoscope, following which a covered metallic stent (18 mm × 60 mm, Microtech, Nanjing, China) was deployed successfully under direct vision [Supplemental Video 2] . Postoperatively, the patient was extubated and was relieved of her stridor. Chest radiograph and flexible bronchoscopy confirmed the successful deployment of the metallic Y-stent.
The subglottic region is the narrowest portion of the trachea in adults. The cricoid is a complete cartilage with a unique inverted signet shape, unlike the remaining trachea where the cartilaginous rings are "c" shaped and incomplete. In an autopsy study from Sweden, the mean inner diameter of the cricoid region was found to be 11.6 mm (range, 8.9-17 mm) in women and 15 mm (range, 11-21.5 mm) in men. [1] Tracheal dimensions were found Single-lung stereotactic body radiotherapy: A Case report and discussion of therapeutic challenges Sir, Management of a second primary lung cancer (SPLC) after prior pneumonectomy (PP) poses a significant therapeutic challenge. Treatment options include sublobar surgical resection, conventional radiotherapy (RT), and stereotactic body RT (SBRT). Low cardiopulmonary reserve limits the use of surgery in a majority of patients. SBRT has been shown to be a safe and effective treatment option for medically inoperable early-stage lung cancer. However, there are limited data on the use of SBRT in patients with a single lung. Herein, we discuss the challenges in the management and case summary of one such patient.
68 year old gentleman presented with an incidentally detected right lung lesion. He had a history of left lung nonsmall cell lung cancer diagnosed in 2012. He received three cycles of neoadjuvant chemotherapy (pemetrexed and carboplatin), followed by preoperative external beam RT to the mediastinum and left hemithorax, using intensity-modulated RT, to a dose of 45 Gy in 25 fractions, following which he underwent a right pneumonectomy and left mediastinal nodal dissection. On routine follow-up, a new opacity was seen in the right lung on chest radiograph. 18-Fluorodeoxyglucose positron emission tomography/computed tomography (CT) scan showed a peripheral upper lobe lung nodule (3.3 cm × 3 cm, maximum standardized uptake value [SUV max ] of 16.6). Another subcentimeter nodule in the right lower lobe was too small to be characterized with low metabolic activity.
His pulmonary evaluation revealed severe obstructive changes with a forced expiratory volume in 1 s of 41% and a reduced diffusion capacity. He was considered unfit for any surgical intervention, including a transthoracic biopsy. His case was discussed in a multidisciplinary clinic, and it was decided to go ahead with SBRT for the larger upper lobe lesion and observe the smaller lesion. The dosimetric parameters from the last radiation were unavailable for review; however, the patient did not have any late radiation sequelae in the lung.
SBRT was planned using standard four-dimensional CT simulation and treatment planning process. The gross disease was contoured on maximum intensity projection images. The internal gross target volume was 12.84 cc,
